Eden Research (LON:EDEN) Trading Down 3.3% – What’s Next?

Eden Research plc (LON:EDEN) dropped 3.3% on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares changed hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The business has a fifty day simple moving average of GBX 3.87 and a two-hundred day simple moving average of GBX 3.95. The company has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92.

Insider Transactions at Eden Research

In other Eden Research news, insider Alexander John Abrey bought 540,540 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,362.19). Also, insider Lykele van der Broek acquired 256,000 shares of the stock in a transaction that occurred on Thursday, February 6th. The stock was purchased at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,958.74). 14.02% of the stock is owned by company insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.